Pepspotter | Peptide News & Prices
@pepspotter
First with peptide news + the clips everyone's talking about. Sourced. Live price compare ↓ RUO only.
11 Following 359 Followers
🚨BREAKING: FDA now requires a vision-loss warning on every GLP-1 label, from Ozempic and Wegovy to Mounjaro, Zepbound and Foundayo.
The risk is NAION, a rare optic nerve event: 6.4 vs 3.8 cases per 100,000 patient-years across 126 trials.
Show more
